Table 1.
Tracer | Dose from monkeys (µSv/MBq) |
Reference | Dose from humans (µSv/MBq) |
Reference | % difference as compared to monkey estimatesa |
% difference as compared to the human meanb |
---|---|---|---|---|---|---|
11C-BTA-1 | 7.4 | Parsey et al. (2005) [7] | 4.3 | Thees et al. (2007) [8] | −72.1 | −25.1 |
11C-(R)-Rolipram | 6.6 | Sprague et al. (2008) [2] | 4.8 | Sprague et al. (2008) [2] | −37.5 | −16.4 |
11C-DASB | 6.2 | Tipre et al. (2004) [9] | 7.0 | Lu et al. (2004) [10] | 11.4 | 21.9 |
11C-PBR28 | 10.3 | Brown et al. (2007) [3] | 6.6 | Brown et al. (2007) [3] | −56.1 | 14.9 |
11C-CUMI-101 | 6.9 | Parsey (unpubl.) | 5.3 | Hines et al. (2011) [11] | −30.2 | −7.7 |
11C-MePPEP | 6.6 | NIMH/SNIDD [12] | 4.6 | Terry et al. (2010) [13] | −43.5 | −19.9 |
11C-dLop | 9.4 | Liow et al. (2009) [14] | 7.8 | Seneca et al. (2009) [15] | −20.5 | 35.8 |
11C-(R)-PK11195 | 5.3 | Our unpubl. data | 5.0 | Hirvonen et al. (2010) [16] | −6.0 | −13.0 |
4.6 | Kumar et al. (2010) [17] | −13 | −19.9 | |||
11C-raclopride | 6.7 | Herscovitch et al. (1997) [18] | 6.3 | Slifstein et al. (2006) [19] | −6.3 | 9.7 |
6.7 | Ribeiro et al. (2005) [20] | 0 | 16.6 | |||
Mean±SD | 7.3±1.6 | 5.7±1.2 | −29.0±26.5 | 0±21.7 |
Obtained for each tracer j by: (human dosej − monkey dosej)*100/human dosej
Obtained for each tracer j by: (human dosej − mean human dose)*100/mean human dose